A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies (Q2104157): Difference between revisions

From MaRDI portal
Set OpenAlex properties.
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: Predictive modeling of neuroblastoma growth dynamics in xenograft model after bevacizumab anti-VEGF therapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: A mathematical model of angiogenesis and tumor growth: analysis and application in anti-angiogenesis therapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q5258360 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of BCG treatment of bladder cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Invariant manifold methods for metabolic model reduction / rank
 
Normal rank
Property / cites work
 
Property / cites work: Analysis of the computational singular perturbation reduction method for chemical kinetics / rank
 
Normal rank
Property / cites work
 
Property / cites work: A cancer treatment based on synergy between anti-angiogenic and immune cell therapies / rank
 
Normal rank
Property / cites work
 
Property / cites work: A mathematical model of tumor-immune interactions / rank
 
Normal rank
Property / cites work
 
Property / cites work: On a modified version of ILDM approach: asymptotic analysis based on integral manifolds / rank
 
Normal rank
Property / cites work
 
Property / cites work: Modeling immunotherapy of the tumor -- immune interaction / rank
 
Normal rank

Latest revision as of 01:49, 31 July 2024

scientific article
Language Label Description Also known as
English
A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies
scientific article

    Statements

    A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies (English)
    0 references
    0 references
    0 references
    9 December 2022
    0 references
    mathematical model
    0 references
    stability analysis
    0 references
    VEGF
    0 references
    anti-VEGF
    0 references
    cancer treatment
    0 references
    angiogenic
    0 references
    tumor vasculature
    0 references

    Identifiers